Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
--------
Question: The justices did not comment in refusing to review an appeals court ruling that upheld the law. Enforcement of the law had been on hold pending the legal challenge but will begin shortly, said Steve Pitt, general counsel to Kentucky Gov. Matt Bevin. The American Civil Liberties Union had challenged the law on behalf of Kentucky's lone remaining abortion clinic. The ACLU argued that "display and describe" ultrasound laws violate physicians' speech rights under the First Amendment. The federal appeals court in Cincinnati upheld the Kentucky law, but its sister court in Richmond, Virginia, struck down a similar measure in North Carolina. The Supreme Court had previously upheld "informed consent" laws for women seeking abortions. The court will hear an abortion case in March, over Louisiana's attempt to require doctors who perform abortions to have admitting privileges at local hospitals. Doctors' speech also has been an issue in non-abortion cases. The federal appeals court in Atlanta struck down parts of a 2011 Florida law that sought to prohibit doctors from talking about gun safety with their patients. Under the law, doctors faced fines and the possible loss of their medical licenses for discussing guns with patients. In Kentucky, doctors must describe the ultrasound in detail while the pregnant woman listens to the fetal heartbeat. Women can avert their eyes and cover their ears to avoid hearing the description or the fetal heartbeat. Doctors failing to comply face fines and can be referred to the state's medical licensing board. The ACLU called the law unconstitutional and unethical. ACLU lawyer Alexa Kolbi-Molinas said that the Supreme Court "has rubber-stamped extreme political interference in the doctor-patient relationship." Pitt painted a different picture of the law. "It's a five-minute procedure that takes place before the abortion is performed to give women who might have a lack of understanding of what's actually in the womb, that this is a real living human being there, they might change their mind," he said. The high court's decision not to review the ultrasound case came on Bevin's final day in office. Bevin, a Republican, is an outspoken abortion opponent. During his term, he signed a series of measures passed by the GOP-led legislature that put limits and conditions on abortion, including the 2017 ultrasound law. Those laws have triggered several legal challenges. Bevin was defeated in last month's election by Democratic Attorney General Andy Beshear, but Republicans remain in control of the state legislature. ___ Associated Press writer Bruce Schreiner contributed to this report from Frankfort, Ky.

Answer: Supreme Court leaves Kentucky's ultrasound law in place.

Question: The St. Louis Post-Dispatch reports that the Missouri Department of Health and Senior Services awarded a no-bid contract to the Missouri Primary Care Association. The agreement will pay the organization $125,000 a year to focus on getting more adolescents to receive at least five vaccines, including influenza, hepatitis A and HPV. Contract talks began before health officials warned last week that a hepatitis A outbreak in the state could grow worse if it spreads to urban areas. Health officials say the state has recorded 414 cases of the virus since September 2017. In previous years, only about 10 cases were reported annually.

Answer: State awards contract to boost hepatitis A vaccination rate.

Question: Negotiations are being held with several big drugs makers as part of a wider drive to bring the cost of so-called artemisinin-based combination therapies (ACTs) down to the level of the older, but now ineffective, chloroquinine treatments. "I am very hopeful that this first stage, the negotiations, will produce results," Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria told reporters in Paris on Tuesday. The negotiations, part of a program called the Affordable Medicines Facility - Malaria (AMFm), aim to persuade drugs companies to cut the price of ACTs to all first-time buyers to $1, the price currently charged to public sector buyers. The AMFm would then subsidize wholesalers 95 percent of the cost, enabling them to sell the drugs at prices within reach of people in some of the world's poorest countries who may be living on $1 or $2 a day. Malaria, a disease spread by mosquito-borne parasites, is contracted by up to 500 million people every year, of whom more than 1 million die, according to figures from the World Health Organization. Chloroquinine, one of the former standard treatments for the disease, has become ineffective in many countries as resistance levels have grown. But its low cost around 20 cents a dose compared with $4-5 for ACTs makes it far more affordable for people living in poor African, Asian or Latin American countries where the disease is most dangerous. Kazatchkine said the program would help drugs companies by increasing the size of the market for ACTs and make it easier to predict demand. "We are seeing the market a lot more clearly now," he said. "Some firms were complaining that they had produced too much of these medicines. We're hoping an agreement will enable us to regulate the flow better so that everyone benefits." Swiss drugs maker Novartis and France's Sanofi are among the Western companies that make the drug but the sector has been shaken by the arrival of Chinese and Indian companies like Cipla and IPCA Laboratories. "The more firms there are producing these medicines, the greater the level of competition will be and the more prices will fall," Kazatchkine said. He said a sharp increase in malaria funding over recent years had improved prospects for controlling the disease but said an extra $1 billion a year was needed. "We have the means to control and combat malaria," he said. "It would be incomprehensible, shocking now that we are so close to being able to reduce it really significantly if we didn't."

Answer:
Malaria campaigners hopeful on drugs pricing deal.